advocate the use of monoclonal antibodies (McAb) to leucocyte common antigen (LCA) and to intermediate filament cytokeratins (Cytok) to distinguish lymphoma (LCA+ Cytok-) from carcinoma (Cytok+ LCA-) in the differential diagnosis of anaplastic tumours. We report here a case ultimately diagnosed as an IgD myeloma where the tumour in the presenting lesion (an enlarged cervical lymph node) clearly expressed LCA and Cytok in the same cells. To our knowledge this is the first such reported observation.
The patient, a 42 year old man, presented with a 6 month history of enlarged lymph nodes in the neck and weight loss of 10kg. On examination, there was mild hepatosplenomegaly and CAT scan demonstrated a mediastinal mass. A cervical lymph node biopsy was formalin fixed, and paraffin sections submitted to histopathological analysis. The histopathologist diagnosed an anaplastic tumour, and suggested an immunoblastic lymphoma (Keil classification). As part of our routine protocol sections were trypsinised and immunostained using a conventional indirect immunoperoxidase method with antibodies to LCA (Dakopatts a/c) and to Cytok (Becton-DickinsonClone CAM 5:2). The results showed the tumour cells positive for both markers. Concurrent positive and negative tissue controls were performed.
More extensive immunostaining was done on the paraffin sections using McAb and polyclonal antibodies to immunoglobulin (Ig) heavy chains (IgD, IgM, IgG, IgA and IgE) and to light chains kappa (K) and lambda (A) (Unipath). The tumour cells (LCA + Cytok +) was positive for A light chains, no Ig heavy chain isotype was detected.
In view of the unique dual phenotype of the tumour cells detected in the fixed tissue, a fresh unfixed second lymph node biopsy was requested. Figure 1) . The finding of positive staining for IgD on the cryostat sections with negative results on the fixed trypsinised sections is compatible with the knowledge that IgD antigenic determinants are very susceptible to denaturation by formalin, heat and trypsin (Jefferis & Mathews, 1977 this is not unprecedented. Epithelial membrane antigen has been shown to be expressed by a small percentage of lymphomas/myeloma (Delsol et al., 1984) ; lymphoid malignancies have been documented which express myeloid markers (Smith et al., 1983 ). Even at the genotypic level using cDNA probes to Ig and T cell receptor genes, a small percentage of lymphoid tumours can be shown to have both T cell and Ig gene rearrangements in the same cells (Pelicci et al., 1985) .
Clearly by clinical and laboratory results our patient has myeloma. Whether the Cytok positivity of his tumour cells merely reflect an isolated malignant aberrant gene expression or may have biological/clinical significance and/or a particular association with IgD tumours must await further investigations and observations. Finally, when investigating anaplastic tumours by immunophenotyping it is important that both antibodies (LCA and Cytok) be used. It should be stressed that this unusual case does not undermine the established usefulness of these antibody markers in the differential diagnosis of anaplastic tumours.
